Chest
Volume 152, Issue 4, October 2017, Pages 899-900
CorrespondencePotential Mechanisms of Microbial Pathogens in Idiopathic Interstitial Lung Disease
Section snippets
Acknowledgments
Role of sponsors: The sponsor had no role in the design of the study, the collection and analysis of the data, or the preparation of the manuscript.
References (5)
- et al.
The role of infection in interstitial lung diseases: a review
Chest
(2017) - et al.
Platelet activating factor receptor: gateway for bacterial chronic airway infection in chronic obstructive pulmonary disease and potential therapeutic target
Expert Rev Respir Med
(2015)
There are more references available in the full text version of this article.
Cited by (11)
Network-based identification genetic effect of SARS-CoV-2 infections to Idiopathic pulmonary fibrosis (IPF) patients
2021, Briefings in BioinformaticsSmoking upregulates angiotensin-converting Enzyme-2 receptor: A potential adhesion site for novel coronavirus SARS-CoV-2 (COVID-19)
2020, Journal of Clinical Medicine
Editor’s Note: Authors are invited to respond to Correspondence that cites their previously published work. Those responses appear after the related letter. In cases where there is no response, the author of the original article declined to respond or did not reply to our invitation.
FINANCIAL/NONFINANCIAL DISCLOSURES: None declared.
FUNDING/SUPPORT: This work was supported by the Clifford Craig Foundation [Grant No. 153 to S. S. S.].
© 2017 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.